Axogen, Inc. (AXGN) earnings date

Nasdaq · Mid cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 32 days, typically, give or take 12 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Wed, Oct 28, 2026before open 28 8-K
Q2 FY2026Wed, Jul 29, 2026before open 29 8-K
Q1 FY2026Tue, Apr 28, 2026before open 28 8-K
Q4 FY2025Tue, Feb 24, 2026before open 55 8-K
Q3 FY2025Wed, Oct 29, 2025before open 29 8-K
Q2 FY2025Tue, Aug 5, 2025before open 36 8-K
Q1 FY2025Thu, May 8, 2025before open 38 8-K
Q4 FY2024Tue, Feb 25, 2025before open 56 8-K

What they guided beta

Q3 FY2026 "Document Exhibit 99.1 Axogen, Inc. Reports Third Quarter 2026 Financial Results Raises Full Year Revenue Guidance to at Least 29% Growth or $290 million ALACHUA and TAMPA, FL – October 28, 2026 – Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today reported financial results and business highlights for the third quarter ended September 30, 2026." exhibit
Q3 FY2026 "We remain well positioned to achieve our 2026 revenue guidance and longer-term strategic objectives.”" exhibit
Q3 FY2026 "A live webcast, an archived replay, and presentation slides from the event will be available on the Investors page of the Company’s website at www.axogeninc.com. 2026 Financial Guidance For 2026, we expect full-year revenue of at least $290 million, representing growth of at least 29%, including at least $7 million revenue from the BioCircuit acquisition." exhibit
Q3 FY2026 "We continue to expect gross margin to be at least 73%, and positive free cash flow for the full-year." exhibit
Q2 FY2026 "Document Exhibit 99.1 Axogen, Inc. Reports Second Quarter 2026 Financial Results Raises Full Year Revenue Guidance to at Least 24% Growth or $279 million ALACHUA and TAMPA, FL – July 29, 2026 – Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today reported financial results and business highlights for the second quarter ended June 30, 2026." exhibit
Q2 FY2026 "We remain well positioned to achieve our revenue guidance and continue advancing our strategic objectives for 2026.”" exhibit
Q2 FY2026 "Acquired a minority ownership stake in Trace Biosciences, including a limited right of first refusal, to support development of its nerve-specific imaging technology. 2026 Financial Guidance For 2026, we expect full-year revenue growth to be at least 24%, or revenue of at least $279 million, gross margin to be at least 73%, and positive free cash flow for the full-year." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/AXGN
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/AXGN

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

AXGN earnings date badge

HTML

<a href="https://veritasdata.dev/company/AXGN/"><img src="https://veritasdata.dev/embed/AXGN.svg" alt="AXGN earnings date" width="240" height="56"></a>

Markdown

[![AXGN earnings date](https://veritasdata.dev/embed/AXGN.svg)](https://veritasdata.dev/company/AXGN/)

Script

<script async src="https://veritasdata.dev/embed/AXGN.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/AXGN"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.